Showing results (181-190 of 321) with videos related to
Sort By:
Pageof 33
Brain Pathology (Zurich, Switzerland)|January 17, 2014
Enlarging the nosological spectrum of hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS)Sarah Hoffmann, Jill Murrell, Lutz Harms, et al.Neurology|December 23, 2016
Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitisFranziska Scheibe, Harald Prüss, Annerose M Mengel, et al.Frontiers in Neurology|December 5, 2018
Exploratory Investigation of Intestinal Function and Bacterial Translocation After Focal Cerebral Ischemia in the MouseNaoki Oyama, Katarzyna Winek, Priscilla Bäcker-Koduah, et al.Molecular Neurodegeneration|April 19, 2015
Intrathecal heat shock protein 60 mediates neurodegeneration and demyelination in the CNS through a TLR4- and MyD88-dependent pathwayKaren Rosenberger, Paul Dembny, Katja Derkow, et al.European Journal of Neurology|January 31, 2022
Daratumumab for treatment-refractory antibody-mediated diseases in neurologyFranziska Scheibe, Lennard Ostendorf, Harald Prüss, et al.European Journal of Neurology|November 14, 2025
AXIN1, STAMBP, ST1A1, CDCP1, and SIRT2 Validated as Myasthenia Gravis Biomarkers: A Comparative Proteomic Study With MS, CIDP, and ControlsAmol K Bhandage, Sarah Hoffmann, Carla Dusemund, et al.Journal of Neurology|October 21, 2019
Daratumumab treatment for therapy-refractory anti-CASPR2 encephalitisFranziska Scheibe, Lennard Ostendorf, S Momsen Reincke, et al.European Journal of Neurology|October 7, 2024
Time to response with ravulizumab, a long-acting terminal complement inhibitor, in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravisAli A Habib, Michael Benatar, Tuan Vu, et al.Der Nervenarzt|December 21, 2021
[Position paper on stroke aftercare of the German Stroke Society-Part 3: structural concepts for future forms of care of stroke aftercare]Christopher J Schwarzbach, Dominik Michalski, Markus Wagner, et al.International Journal of Stroke : Official Journal of the International Stroke Society|August 29, 2012
STRoke Adverse outcome is associated WIth NoSocomial Infections (STRAWINSKI): procalcitonin ultrasensitive-guided antibacterial therapy in severe ischaemic stroke patients - rationale and protocol for a randomized controlled trialLena Ulm, Stephanie Ohlraun, Hendrik Harms, et al.Pageof 33